83
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Analgesic Effect of Hexane Fraction from Roots of Lonchocarpus sericeus

, , &
Pages 429-434 | Published online: 29 Sep 2008

References

  • Aarestrup FM, Gonçalves-da-Costa SC, Sarno EN (1995): The effect of thalidomide on BCG-induced granuloma in mice. Braz J Med Biol Res 28: 1069–1076.
  • Abacioglu N, Tunctan B, Akbulut E, Cakici 1(2000): Participa-tion of the components of L-arginine/nitric oxide/cGIVIP cascade by chemically-induced abdominal constrictions in the mouse. Life Sci 67: 1127–1137.
  • Beutler B, Cerami A (1988): Tumor necrosis, cachexia, shock and inflammation: A common mediator. Annu Rev Bioch 57: 505–518.
  • Cho JY, Kim PS, Park J, Yoo ES, Baik KU, Kim Y, Park MH (2000): Inhibitor of tumor necrosis factor-alpha production in lipopolysaccharide stimulated RAW 264.7 cells from Amorpha fruticosa. J Ethnopharmacol 70: 127–133.
  • Cunha FQ, Poole S, Lorenzetti BB, Ferreira SH (1992): The pivotal role of tumor necrosis factor alpha in the develop-ment of inflammatory hyperalgesia. Br J Pharmacol 107: 660–664.
  • De Mello JF, De Lima OG, De Albuquerque MM, Marini-Betted° GB, Lyra FD, Da Silva EC (1974): 0 and C preny-late chalcones with antineoplastic and antibiotic activities from Lonchocarpus neuroscapha Benth. Rev Inst Antibiot (Recife) 14: 39–50.
  • Duarte ID, Ferreira SH (2000): L-NAME causes antinociception by stimulation of the arginine-NO-cGIVIP pathhway medi-ators. Inflammation 9: 25–30.
  • Eddy NB, Leimbach D (1953): Synthetic analgesics. II. Dithienybutenyl and Dithienylbutylamines. J Pharmacol Exp Ther 107: 385–393.
  • Elbein AD, Mitchell M, Sanford BA, Fellows LE, Evans SV (1984): The pyrrolidine alkaloid, 2,5-dihydroxymethy1-3,4-dihydroxypyrrolidine, inhibits glicoprotein processing. J Biol Chem 259: 12409–12413.
  • Ferreira SH (1972): Prostaglandins, aspirin-like drugs and anal-gesia. Nature New Biol 240: 200–203.
  • Got-waives de Lima 0, De Mello JF, De Barros Coelho JS, De Andrade Lyra FD, Machado de Albuquerque M, Marini-Betted° GB, Delle Monache G, Delle Monache F (1975): New prenylated chalcones from Lonchocarpus neu-roscapha Benth. (Cordoa piaca). Farmaco [Sci] 30: 326–342.
  • Gyires K, Torma Z (1984): The use of writhing test in mice for screening different types of analgesics. Arch Int Pharmacodyn 267: 131–140.
  • Hayashi A, Gillen AC, Lott JR (2000): Effects of daily oral administration of quercetin chalcone and modified citrusP•ectin Ahern Med Rev 5: 546–552.
  • Herencia F, Ferrandiz ML, Ubeda A, Guillen I, Dominguez JN, Charris JE, Lobo GM, Alacaraz MJ (2001): 4-dimethylamino-3',4'-dimethoxychalconedownregulates
  • iNOS expression and exerts anti-inflammatory effects. Free Radic Biol Med 30: 43–50.
  • Hunskaar S, Fasmer OB, Hole K (1985): Formalin test in mice: a useful technique for evaluating mild analgesics. J Neu-rosci Meth 14: 69–76.
  • Hunskaar S, Hole K (1987): The formalin test in mice: dissoci-ation between inflammatory and non-inflammatory pain. Pain 30: 103–114.
  • Iwu IV11VI, Anyanwu BN (1982): Phytotherapeutic profile of Nigerian herbs. I: Anti-inflammatory and anti-arthritic agents. J Ethnopharmacol 6: 263–274.
  • Koster R, Anderson M, de Beer J (1959): Acetic acid analgesic screening. Fed Proc 18: 412–417.
  • Le J, Vilceky J (1987): Tumor necrosis factor and interleukin I: cytokines with multiple overlapping biological activities. Lab Invest 56: 234–248.
  • Lebeau J, Furman C, Bernier J, Duriez P, Teissier E, Cotelle N (2000): Antioxidant properties of di-tert-butylhydroxylated flavonoids. Free Radic Biol Med 29: 900–912.
  • Lupi A, Delle Monache G, Delle Monache F, Marini-Bettelo GB, Goncalves de Lima 0, De Mello JF (1977): Synthetic analogs of natural prenylated and chromene chalcones. Farmaco [Sa] 32: 261–269.
  • Moore PK, Oluyoni AO, Babbedge RC, Wallace P, Hart SL (1991): L-NG-nitro arginine methyl esther exhibits antinociceptive activity in the mouse. Br J Pharmacol 102: 198–202.
  • Moreira LA, Sampaio EP, Zimuidzinas A, Frind P, Smith KA, Kaplan G (1993): Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degra-dation. J Exp Med 177: 1675–1680.
  • Moreira LA, Wang J, Sarno EN (1997): Thalidomide protects mice against LPS-induced shock. Braz J Med Biol Res 30: 1199–1202.
  • Moretti C, Grenand P (1982): The "nivrées", or ichthyotoxic
  • plants of French Guyana. J Ethnopharmacol 6: 139–160. Old LJ (1987): Tumor necrosis factor. Another chapter in thelong history of endotoxin. Nature 330: 602–603.
  • Pettibone DJ, Mueller GP (1989): Alpha adrenergic stimulation by clonidin increases plasma concentration of imm-unoreactive beta-endorphin in rats. Endocrinology 109: 789–802.
  • Ribeiro RA, Vale ML, Ferreira SH, Cunha FQ (2000b): An-algesic effect of thalidomide on inflammatory pain. Eur J Pharmacol 391: 97–103.
  • Ribeiro RA, Vale ML, Thomazzi SM, Paschoalato ABP, Poole S, Ferreira SH, Cunha FQ (2000a): Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice. Eur J Pharmacol 387: 111–118.
  • Sampaio EP, Sarno EN, Galilly R, Kohn ZA, Kaplan Z (1991): Thalidomide selectively inhibits tumor necrosis factor-a production by stimulated human monocytes. J Exp Med 173: 699–703.
  • Takahashi RN, Paz MiM (1987): Influence of naloxone on an-algesic effects of antidepressants in mice. Brazilian J Med Biol Res 20: 607–610.
  • Vander WC, Margolin S (1956): Analgesic test based upon experimentally induced acute abdominal pain in rats. Fed Proc 15: 494.
  • Vassalli P (1992): The pathophysiology of tumor necrosis factor. Annu Rev Immunol 10: 411–452.
  • Yasksh TI, Rudy TA (1977): Studies on the direct spinal action of narcotics on the production of analgesia in the rat. J Pharmacol Exp Ther 202: 411–428.
  • Yeh SY (1986): Potentiation of pentazocine antinociception by tripelenamine in the rat. J Pharmacol Exp Ther 235: 683–688.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.